Carbamic acid, 1-[(6-bromo-2-pyridinyl)methyl]-4-piperidinyl-, 1,1-dimethylethyl ester, commonly referred to by its CAS number 303763-37-3, is a chemical compound characterized by its complex structure that includes a carbamate functional group. This compound features a piperidine ring, which contributes to its potential biological activity, and a brominated pyridine moiety that may enhance its pharmacological properties. The presence of the tert-butyl ester group suggests that it may exhibit lipophilic characteristics, influencing its solubility and permeability in biological systems. As a carbamate derivative, it may interact with enzymes such as acetylcholinesterase, which is relevant in the context of neuropharmacology. The compound's specific applications and effects would depend on its interaction with biological targets, making it of interest in medicinal chemistry and drug development. However, detailed studies would be necessary to fully elucidate its properties, including its stability, reactivity, and potential therapeutic uses.

Carbamic acid,[1-[(6-bromo-2-pyridinyl)methyl]-4-piperidinyl]-, 1,1-dimethylethyl ester (9CI)

303763-37-3: Carbamic acid, 1-[(6-bromo-2-pyridinyl)methyl]-4-piperidinyl-, 1,1-dimethylethyl ester, commonly referred to by its CAS number 303763-37-3, is a chemical compound characterized by its complex structure that includes a carbamate functional group. This compound features a piperidine ring, which contributes to its potential biological activity, and a brominated pyridine moiety that may enhance its pharmacological properties. The presence of the tert-butyl ester group suggests that it may exhibit lipophilic characteristics, influencing its solubility and permeability in biological systems. As a carbamate derivative, it may interact with enzymes such as acetylcholinesterase, which is relevant in the context of neuropharmacology. The compound's specific applications and effects would depend on its interaction with biological targets, making it of interest in medicinal chemistry and drug development. However, detailed studies would be necessary to fully elucidate its properties, including its stability, reactivity, and potential therapeutic uses.

CAS 303763-37-3

Carbamic acid,[1-[(6-bromo-2-pyridinyl)methyl]-4-piperidinyl]-, 1,1-dimethylethyl ester (9CI)

Carbamic acid, [1-[(6-bromo-2-pyridinyl)methyl]-4-piperidinyl]-, 1,1-dimethylethyl ester (9CI)

Ref: IN-DA002ZW8